Visitors Now:
Total Visits:
Total Stories:
Profile image
Story Views

Now:
Last Hour:
Last 24 Hours:
Total:

Atrial Fibrillation Market Drugs Sales Forecast 2020

Monday, November 28, 2016 12:42
% of readers think this story is Fact. Add your two cents.

(Before It's News)

Publisher Report “Atrial Fibrillation-Market Insights & Drugs Sales Forecast (AF) -2020″ provides an overview of the Atrial Fibrillation indication. The Report majorly emphasize on the global market size Atrial Fibrillation. The Report provides Anticoagulants market size and Anticoagulants by 7Major Markets (United States, EU5 (France, Germany, Italy, Spain, UK) and Japan) in Atrial Fibrillation indication.

The Report provides comprehensive review of Market Drivers, Market barriers, Anticoagulants with coverage of detailed profile, Cost of therapy, Safety and Efficacy profiles and SWOT analysis, The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by Publisher team of industry experts.

 

For more information about this report: http://www.reportsweb.com/atrial-fibrillation-market-insights-and-drugs-sales-forecast-af-2020

Executive Summary
Market Share of Anticoagulants in 2015 and 2020
Worldwide Market Share of Anticoagulants in 2015
Worldwide Market Share of Anticoagulants in 2020
Chapter 1 Anticoagulants Introduction
Warfarin
Low Molecular Weight Heparins
New Oral Anticoagulants (NOAC)
Chapter 2 Atrial Fibrillation
Disease Overview
Epidemiology of Atrial Fibrillation
Treatment Landscape
Treatment Algorithm
Treatment Goals
Treatment Details
Chapter 3 Key Marketed Anticoagulants
Novel Oral Anticoagulants Comparison
Reversal Agents (Antidotes)
Chapter 4 Anticoagulants Market Assessment by AF
Key Findings
Global Anticoagulants Market Sales by Atrial Fibrillation (AF)
Global Anticoagulants Market Share (%) in Atrial Fibrillation
Chapter 5 United States Anticoagulants Market Assessment by AF
Key Findings
United States Anticoagulants Market Sales by Atrial Fibrillation
United States Anticoagulants Market Share (%) in Atrial Fibrillation
Chapter 6 Europe 5 Anticoagulants Market Assessment by AF
Key Findings
Europe 5 Anticoagulants Market Sales by Atrial Fibrillation
Europe 5 Anticoagulants Market Share (%) in Atrial Fibrillation
Chapter 7 Japan Anticoagulants Market Assessment by AF
Key Findings
Japan Anticoagulants Market Sales by Atrial Fibrillation
Japan Anticoagulants Market Share (%) in Atrial Fibrillation
Chapter 8 Xarelto (rivaroxaban) Drug Profile
 

Request Sample Copy at http://www.reportsweb.com/inquiry&RW0001337198/sample

 

Product Profile
Advantages & Disadvantages
Efficacy of Xarelto
Safety of Xarelto
Side effects of Drugs
Cost of Therapy
Global Drug Sales
Xarelto Historical Sales and Forecasted Sales (2011-2020)
Global Drug Sales by indication
Xarelto Historical Sales and Forecasted Sales (2011-2020) by AF
Clinical Trials Information
SWOT Analysis of Xarelto
Chapter 9 Pradaxa (dabigatran etexilate mesylate) Drug Profile
Product Profile
Advantages & Disadvantages
Efficacy of Pradaxa
Safety of Pradaxa
Side effects of Drugs
Cost of Therapy
Global Drug Sales
Pradaxa Historical Sales and Forecasted Sales (2011-2020)
Global Drug Sales by indication
Pradaxa Historical Sales and Forecasted Sales (2011-2020) by AF
Clinical Trial Information
SWOT Analysis of Pradaxa
Chapter 10 Eliquis(Apixaban) Drug Profile
Product Profile
Advantages & Disadvantages
Efficacy and Safety of Eliquis
Side effects of Eliquis
Cost of Therapy
Global Drug Sales
Eliquis Historical Sales and Forecasted Sales (2011-2020)
Global Drug Sales by indication
Eliquis Historical Sales and Forecasted Sales (2011-2020) by AF
Clinical Trial Information
SWOT Analysis of Eliquis
Chapter 11 Savaysa (edoxaban tosylate) Drug Profile
Product Profile
Advantages & Disadvantages
Efficacy of Savaysa
Safety of Savaysa
Side Effects of Savaysa
Cost of Therapy
Global Drug Sales
Savaysa Historical Sales and Forecasted Sales (2011-2020)
Global Drug Sales by indication
Savaysa Historical Sales and Forecasted Sales (2011-2020) by AF
Clinical Trial Information
SWOT Analysis of Savaysa
Chapter 12 Market Drivers and Constraints
Factors Driving the Market Growth
Factors Constraining the Market Growth

 

Inquire before Buying at http://www.reportsweb.com/inquiry&RW0001337198/buying

 

Contact Us:

Call: +1-646-491-9876
Email: sales@reportsweb.com

Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories

Register

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.